The Man Who Survived Ebola: 'We Thought It Was Going to Kill Me'

NBC News Clone summarizes the latest on: Man Who Survived Ebola We Thought It Was Going Kill N172601 - Breaking News | NBC News Clone. This article is rewritten and presented in a simplified tone for a better reader experience.

Dr. Thomas Cairns was quite possibly the first non-African Ebola patient — and would become, almost certainly, the first non-African Ebola survivor.
Get more newsMan Who Survived Ebola We Thought It Was Going Kill N172601 - Breaking News | NBC News Cloneon

In 1972, a full four years before the Ebola virus even had a name, Dr. Thomas Cairns was a young doctor doing missionary work in the dense jungles of Zaire — a sprawling central African nation now known as the Democratic Republic of Congo.

A very sick patient came into Cairns' clinic and died before doctors could offer a diagnosis. This was not particularly extraordinary, given the panoply of exotic infectious diseases native to the region. The local authorities requested an autopsy to see if they couldn’t figure out what killed this person so quickly. During the procedure, Cairns nicked himself with a scalpel, drawing blood. It was that moment that he became, quite possibly, the first non-African Ebola patient — and would become, almost certainly, the first non-African Ebola survivor.

"Twelve days later I became acutely ill," Cairns said. "I had a very high fever, intense aching, headache, vomiting, diarrhea, rash. My skin was peeling. I lost hearing in one ear for weeks. My hair turned white. We didn't know what was happening to me."

The illness that was ravaging Cairns' body was unlike anything any of the local medical staff had ever seen. "We thought it was going to kill me," he said. "That was a real possibility."

But, instead — inexplicably — Cairns began to feel better. It took weeks, but he was eventually able to get back on his feet, and even began practicing again, part-time at first and then back to a normal schedule. He didn't travel back to the U.S., opting instead to continue his work in the small villages that dotted the western and central African landscape. For four years, the illness that nearly took his life remained a mystery.

Then, in 1976, two nearly simultaneous outbreaks of a similar deadly virus in Sudan and Zaire took hundreds of lives in a short period of time. It flagged the attention of the Center for Disease Control, which began intensive epidemic research in the region, alongside the World Health Organization. As officials looked for the source of the virus that was decimating those who came in contact with it, they coined a name for it: Ebola, after the river that ran near the village of Yambuku, ground zero of what was becoming a serious epidemic.

Image: Dr. Thomas Cairns
Dr. Thomas Cairns with Bama in the operating room in Tandala.Courtesy Dr. Thomas Cairns

At the time, Cairns recalled, epidemiologists had fanned out across the region to collect blood samples from the indigenous population. They also took samples from about 50 expatriates working and living in the area. Cairns was included in the sample, and stood out immediately: He was the only one who carried a large amount of antibodies resistant to the Ebola virus.

That antibody level implied to doctors that Cairns had at one time been exposed to Ebola and had successfully fought it off. He was, effectively, immune to one of the most lethal diseases nature has ever produced.

"That's when we knew: I was, in all likelihood, the first non-African survivor of the Ebola virus," he said.

Cairns, 71, now semi-retired and working at an urgent care facility in a suburb of Minneapolis, did more than just survive. Health officials were so enamored with the level of Ebola antibodies they discovered in his blood that they took samples to store in the CDC freezers in Atlanta, to study and to use to help treat those who may come in contact with the virus in the future. (Over those initial years, Cairns gave several specimens to health workers but his antibody levels eventually lessened as he grew older, making his blood less immune to the disease than it once was.)

With the latest Ebola outbreak among the most deadly in the virus' 40-odd-year lifespan, Cairns remembered those weeks in '72 for the lack of information he and his colleagues had to work with. "We knew this thing was really bad, but that was about it."

Yet, decades later, even modern medicine and pathology have limits: Ebola's kill rate remains stubbornly high. In past outbreaks, as much as 90 percent of those who contract the disease have died from it. In the current outbreak, the rate appears to be about 60 percent.

Cairns credits his faith for not becoming one of those statistics. "It was literally the grace of God that brought me around back then," he said.

AdBlock Detected!
Please disable it to support our content.
×

Related Articles

Donald Trump Presidency Updates - Politics and Government | NBC News Clone | Joe Biden Campaign News - Politics and Government | NBC News Clone | Kamala Harris Vp Announcement - Politics and Government | NBC News Clone | Trump Indictment Latest - Politics and Government | NBC News Clone | Election Results Live - Politics and Government | NBC News Clone | Swing States Polling - Politics and Government | NBC News Clone | Debate Highlights - Politics and Government | NBC News Clone | Budget Approval 2025 - Politics and Government | NBC News Clone | Abortion Ruling - Politics and Government | NBC News Clone | Us China Relations - Politics and Government | NBC News Clone | Inflation Rates 2025 Analysis - Business and Economy | NBC News Clone | Federal Reserve Interest Rates - Business and Economy | NBC News Clone | Stock Market Today - Business and Economy | NBC News Clone | Recession Prediction 2025 - Business and Economy | NBC News Clone | Jobs Report Unemployment - Business and Economy | NBC News Clone | Ai Stock Surge - Business and Economy | NBC News Clone | Housing Market Crash - Business and Economy | NBC News Clone | Oil Prices Update - Business and Economy | NBC News Clone | Amazon Prime Sales - Business and Economy | NBC News Clone | Bitcoin Etf Approval - Business and Economy | NBC News Clone | Latest Vaccine Developments - Health and Medicine | NBC News Clone | Covid Variants Update - Health and Medicine | NBC News Clone | Boosters New Guidelines - Health and Medicine | NBC News Clone | Anxiety Depression Treatment - Health and Medicine | NBC News Clone | Longevity Research - Health and Medicine | NBC News Clone | Diet Trends 2025 - Health and Medicine | NBC News Clone | Workout Routines - Health and Medicine | NBC News Clone | Fda Approvals 2025 - Health and Medicine | NBC News Clone | Ukraine Russia Conflict Updates - World News | NBC News Clone | Israel Palestine War News - World News | NBC News Clone | China Taiwan Tensions - World News | NBC News Clone | Middle East Peace Talks - World News | NBC News Clone | European Union Politics - World News | NBC News Clone | Development News - World News | NBC News Clone | North Korea Missile Test - World News | NBC News Clone | Brazil Election - World News | NBC News Clone | Openai Chatgpt News - Technology and Innovation | NBC News Clone | Google Bard Ai - Technology and Innovation | NBC News Clone | Ai Regulation Laws - Technology and Innovation | NBC News Clone | Tiktok Ban Update - Technology and Innovation | NBC News Clone | Data Breaches 2025 - Technology and Innovation | NBC News Clone | Iphone 16 Release - Technology and Innovation | NBC News Clone | Nasa Mars Mission - Technology and Innovation | NBC News Clone | Web3 Developments - Technology and Innovation | NBC News Clone | 2024 Paris Games Highlights - Sports and Recreation | NBC News Clone | Super Bowl 2025 Preview - Sports and Recreation | NBC News Clone | Nba Playoffs 2025 - Sports and Recreation | NBC News Clone | Champions League Finals - Sports and Recreation | NBC News Clone | World Series 2025 - Sports and Recreation | NBC News Clone | Masters Tournament 2025 - Sports and Recreation | NBC News Clone | Extreme Weather Events - Weather and Climate | NBC News Clone | Hurricane Season 2025 - Weather and Climate | NBC News Clone | Global Warming Report - Weather and Climate | NBC News Clone | Weekly Weather Update - Weather and Climate | NBC News Clone | Earthquake Alerts - Weather and Climate | NBC News Clone | Solar Storm Warning - Weather and Climate | NBC News Clone | Hollywood Updates - Entertainment and Celebrity | NBC News Clone | Oscar Nominations 2025 - Entertainment and Celebrity | NBC News Clone | Grammy Awards 2025 - Entertainment and Celebrity | NBC News Clone | Netflix New Releases - Entertainment and Celebrity | NBC News Clone | Video Game Releases - Entertainment and Celebrity | NBC News Clone | Bestseller List - Entertainment and Celebrity | NBC News Clone | Government Transparency - Investigations and Analysis | NBC News Clone | Political Corruption - Investigations and Analysis | NBC News Clone | Big Tech Monopoly - Investigations and Analysis | NBC News Clone | Data Privacy Scandal - Investigations and Analysis | NBC News Clone | Community Stories - Local News and Communities | NBC News Clone | Nyc Mayor News - Local News and Communities | NBC News Clone | La Wildfires Update - Local News and Communities | NBC News Clone | Hurricane Preparedness - Local News and Communities | NBC News Clone